Stay updated on Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.

Latest updates to the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page
- Check7 days agoChange DetectedAdded revision v3.4.3 to the record history and removed v3.4.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding/operating status notice (v3.4.1).SummaryDifference0.7%

- Check42 days agoChange DetectedA site-wide notice about potential delays due to a lapse in government funding and the revised page version tag (v3.4.1) were added, while the previous tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check50 days agoChange DetectedAdded a glossary display option and color-coded history highlights, and updated the revision label to v3.4.0 with minor wording changes (e.g., 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check64 days agoChange DetectedA new revision entry v3.3.4 was added and the previous v3.3.3 was removed in the Record History for NCT04150965. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2 in the footer, representing minor metadata updates rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.